418 related articles for article (PubMed ID: 23488985)
1. Treatment with hydrogen sulfide alleviates streptozotocin-induced diabetic retinopathy in rats.
Si YF; Wang J; Guan J; Zhou L; Sheng Y; Zhao J
Br J Pharmacol; 2013 Jun; 169(3):619-31. PubMed ID: 23488985
[TBL] [Abstract][Full Text] [Related]
2. Curcumin Attenuates Retinal Vascular Leakage by Inhibiting Calcium/Calmodulin-Dependent Protein Kinase II Activity in Streptozotocin-Induced Diabetes.
Li J; Wang P; Ying J; Chen Z; Yu S
Cell Physiol Biochem; 2016; 39(3):1196-208. PubMed ID: 27595397
[TBL] [Abstract][Full Text] [Related]
3. Α-Melanocyte-Stimulating Hormone Protects Early Diabetic Retina from Blood-Retinal Barrier Breakdown and Vascular Leakage via MC4R.
Cai S; Yang Q; Hou M; Han Q; Zhang H; Wang J; Qi C; Bo Q; Ru Y; Yang W; Gu Z; Wei R; Cao Y; Li X; Zhang Y
Cell Physiol Biochem; 2018; 45(2):505-522. PubMed ID: 29402864
[TBL] [Abstract][Full Text] [Related]
4. Extract of Polygonum cuspidatum Attenuates Diabetic Retinopathy by Inhibiting the High-Mobility Group Box-1 (HMGB1) Signaling Pathway in Streptozotocin-Induced Diabetic Rats.
Sohn E; Kim J; Kim CS; Lee YM; Kim JS
Nutrients; 2016 Mar; 8(3):140. PubMed ID: 26950148
[TBL] [Abstract][Full Text] [Related]
5. Mitochondria-targeted antioxidant peptide SS31 protects the retinas of diabetic rats.
Huang J; Li X; Li M; Li J; Xiao W; Ma W; Chen X; Liang X; Tang S; Luo Y
Curr Mol Med; 2013 Jul; 13(6):935-45. PubMed ID: 23745582
[TBL] [Abstract][Full Text] [Related]
6. Intravitreal injection of erythropoietin protects both retinal vascular and neuronal cells in early diabetes.
Zhang J; Wu Y; Jin Y; Ji F; Sinclair SH; Luo Y; Xu G; Lu L; Dai W; Yanoff M; Li W; Xu GT
Invest Ophthalmol Vis Sci; 2008 Feb; 49(2):732-42. PubMed ID: 18235022
[TBL] [Abstract][Full Text] [Related]
7. Effect of antioxidant N-acetylcysteine on diabetic retinopathy and expression of VEGF and ICAM-1 from retinal blood vessels of diabetic rats.
Zhu Y; Zhang XL; Zhu BF; Ding YN
Mol Biol Rep; 2012 Apr; 39(4):3727-35. PubMed ID: 21952821
[TBL] [Abstract][Full Text] [Related]
8. Effect of memantine on neuroretinal function and retinal vascular changes of streptozotocin-induced diabetic rats.
Kusari J; Zhou S; Padillo E; Clarke KG; Gil DW
Invest Ophthalmol Vis Sci; 2007 Nov; 48(11):5152-9. PubMed ID: 17962468
[TBL] [Abstract][Full Text] [Related]
9. Effect of dual PPAR-α/γ agonist saroglitazar on diabetic retinopathy and oxygen-induced retinopathy.
Joharapurkar A; Patel V; Kshirsagar S; Patel MS; Savsani H; Jain M
Eur J Pharmacol; 2021 May; 899():174032. PubMed ID: 33753107
[TBL] [Abstract][Full Text] [Related]
10. Decreased lysyl oxidase level protects against development of retinal vascular lesions in diabetic retinopathy.
Kim D; Mecham RP; Nguyen NH; Roy S
Exp Eye Res; 2019 Jul; 184():221-226. PubMed ID: 31022398
[TBL] [Abstract][Full Text] [Related]
11. A combination of the main constituents of Fufang Xueshuantong Capsules shows protective effects against streptozotocin-induced retinal lesions in rats.
Jian W; Yu S; Tang M; Duan H; Huang J
J Ethnopharmacol; 2016 Apr; 182():50-6. PubMed ID: 26692279
[TBL] [Abstract][Full Text] [Related]
12. Hydrogen-rich saline prevents early neurovascular dysfunction resulting from inhibition of oxidative stress in STZ-diabetic rats.
Feng Y; Wang R; Xu J; Sun J; Xu T; Gu Q; Wu X
Curr Eye Res; 2013 Mar; 38(3):396-404. PubMed ID: 23252792
[TBL] [Abstract][Full Text] [Related]
13. Study of the influence of angiostatin intravitreal injection on vascular leakage in retina and iris of the experimental diabetic rats.
Sima J; Ma J; Zhang SX; Guo J
Yan Ke Xue Bao; 2006 Dec; 22(4):252-8. PubMed ID: 17378159
[TBL] [Abstract][Full Text] [Related]
14. Erythropoietin protects retinal neurons and glial cells in early-stage streptozotocin-induced diabetic rats.
Zhu B; Wang W; Gu Q; Xu X
Exp Eye Res; 2008 Feb; 86(2):375-82. PubMed ID: 18191124
[TBL] [Abstract][Full Text] [Related]
15. Protective Effects of Leukemia Inhibitory Factor on Retinal Vasculature and Cells in Streptozotocin-induced Diabetic Mice.
Yang XF; Huang YX; Lan M; Zhang TR; Zhou J
Chin Med J (Engl); 2018 Jan; 131(1):75-81. PubMed ID: 29271384
[TBL] [Abstract][Full Text] [Related]
16. Hydrogen Sulfide: A Potential Therapeutic Target in the Development of Diabetic Retinopathy.
Mohammad G; Radhakrishnan R; Kowluru RA
Invest Ophthalmol Vis Sci; 2020 Dec; 61(14):35. PubMed ID: 33372981
[TBL] [Abstract][Full Text] [Related]
17. Fenofibrate Ameliorates Oxidative Stress-Induced Retinal Microvascular Dysfunction in Diabetic Rats.
Li J; Wang P; Chen Z; Yu S; Xu H
Curr Eye Res; 2018 Nov; 43(11):1395-1403. PubMed ID: 30024319
[TBL] [Abstract][Full Text] [Related]
18. Nrf2 Activation Is a Potential Therapeutic Approach to Attenuate Diabetic Retinopathy.
Deliyanti D; Alrashdi SF; Tan SM; Meyer C; Ward KW; de Haan JB; Wilkinson-Berka JL
Invest Ophthalmol Vis Sci; 2018 Feb; 59(2):815-825. PubMed ID: 29411009
[TBL] [Abstract][Full Text] [Related]
19. Bergenin alleviates Diabetic Retinopathy in STZ-induced rats.
Yin Y; Xu R; Ning L; Yu Z
Appl Biochem Biotechnol; 2023 Sep; 195(9):5299-5311. PubMed ID: 35622274
[TBL] [Abstract][Full Text] [Related]
20. Retinoprotective effect of agmatine in streptozotocin-induced diabetic rat model: avenues for vascular and neuronal protection : Agmatine in diabetic retinopathy.
Abo El Gheit RE; Soliman NA; Badawi GA; Madi NM; El-Saka MH; Badr SM; Emam MN
J Physiol Biochem; 2021 May; 77(2):305-320. PubMed ID: 33635523
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
